Profiel
Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd. and the Chief Business Officer at Autifony Therapeutics Ltd. She holds a doctorate degree from the University of Oxford.
Actieve functies van Barbara Domayne Hayman
| Bedrijven | Functie | Begin |
|---|---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Lid van de Investeringscommissie | - |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Corporate Officer/Principal | - |
Opleiding van Barbara Domayne Hayman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Finance |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Health Technology |
















